TG Therapeutics financials at a glance
| Year | Year | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.02M | $0.15M | $0.15M | $0.15M | $0.15M | $0.15M | $0.15M | $0.15M | $0.15M | $6.69M | $2.79M | $233.66M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 88.19% | 90.48% | 93.95% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -69.24% | 8.83% | 0.00% |
| EPS | Earnings Per Share |
|
$-1.17 | $-0.70 | $-1.64 | $-1.38 | $-1.60 | $-1.91 | $-2.30 | $-1.96 | $-2.42 | $-2.63 | $-1.46 | $0.09 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.00% | 0.00% | 0 |
| Sha. | Shares |
|
0.13m | 13.77m | 27.13m | 37.52m | 52.52m | 47.72m | 70.65m | 76.79m | 98.1m | 128.85m | 128.85m | 130.79m | 141.46m | 141.46m |
| OCF | Operating Cash Flow |
|
$-0.13M | $-5.19M | $-10.74M | $-35.06M | $-44.69M | $-61.59M | $-93.76M | $-128.93M | $-132.81M | $-214.51M | $-295.63M | $-176.17M | $0.00M | $0.00M |
| FCF | Free Cash Flow |
|
$0.00M | $0.00M | $-10.83M | $-35.08M | $-44.73M | $-61.94M | $-93.77M | $-129.02M | $-133.91M | $-214.86M | $-296.04M | $-176.18M | $40.03M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.07 | $-0.40 | $-0.42 | $-1.03 | $-0.98 | $-1.26 | $-1.51 | $-1.71 | $-1.50 | $-1.86 | $-2.24 | $-1.30 | $0.00 | $0.00 |